Characteristics and Treatment Patterns of Patients With Sickle Cell Disease in Globin Research Network for Data and Discovery Registry

Novartis

Status: Completed

Conditions: Sickle Cell Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT06662812

CSEG101AUS19

Details and patient eligibility

About

This was a retrospective observational cohort study. This study was a secondary analysis of individuals with sickle cell disease (SCD) enrolled in the GRNDaD registry.

Enrollment: 1,665 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of SCD.
• Signed consent to participate in GRNDaD registry.

Exclusion criteria

• None identified at this time.

Trial design

1,665 participants in 1 patient group

GRNDaD Cohort

Description:

Patients with sickle cell disease (SCD) who were included in the GRNDaD registry and received a disease modifying therapy (DMT).